The popularity of Sildenafil initially fueled a boom for pharma, nevertheless recent shifts present a complicated outlook for investors. Off-patent alternatives are eroding earnings, and persistent legal battles add https://theoynyn006332.oblogation.com/40026968/viagra-and-big-pharma-a-precarious-investment